We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+2.33%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$12.7M
(-7%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-7.34%
Top 10 Holdings %
Top 10 Hldgs %
60.5%
Holding
104
New
11
Increased
13
Reduced
10
Closed
4
Avg Time Held
3
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
+$1.77M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.29M |
| 3 |
TG Therapeutics
TGTX
|
+$892K |
| 4 |
Kyntra Bio
KYNB
|
+$849K |
| 5 |
Gilead Sciences
GILD
|
+$763K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stericycle Inc
SRCL
|
+$6.7M |
| 2 |
ChemoCentryx, Inc.
CCXI
|
+$3.69M |
| 3 |
KKR & Co
KKR
|
+$2.8M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$2.73M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
+$2.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.75% |
| 2 | Financials | 15.96% |
| 3 | Industrials | 12.97% |
| 4 | Technology | 9.76% |
| 5 | Communication Services | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Valley National Bancorp
VLY
$7B
| $86K | 0.05% |
12,480
| – | – |
2019 Q4
3 quarters
|
|
77
Cardiff Oncology
CRDF
$70.1M
| $71K | 0.04% |
+5,000
| New | +$33K |
2020 Q3
0 quarters
|
|
78
FNB Corp
FNB
$6.13B
| $60K | 0.04% |
8,905
| – | – |
2014 Q3
24 quarters
|
|
79
Capitol Federal Financial
CFFN
$1.01B
| $54K | 0.03% |
5,800
| – | – |
2013 Q2
29 quarters
|
|
80
Eli Lilly
LLY
$1.12T
| $44K | 0.03% |
300
| – | – |
2013 Q3
28 quarters
|
|
81
Occidental Petroleum
OXY
$62.4B
| $30K | 0.02% |
2,973
| – | – |
2019 Q3
4 quarters
|
|
82
GE Aerospace
GE
$326B
| $29K | 0.02% |
939
| – | – |
2013 Q2
29 quarters
|
|
83
AC Immune
ACIU
$238M
| $26K | 0.02% |
+5,309
| New | +$38.1K |
2020 Q3
0 quarters
|
|
84
Chemours
CC
$1.92B
| $24K | 0.01% |
1,160
| – | – |
2015 Q3
20 quarters
|
|
85
Eagle Materials
EXP
$5.22B
| $20K | 0.01% |
228
| – | – |
2013 Q2
29 quarters
|
|
86
Scotiabank
BNS
$111B
| $17K | 0.01% |
400
| – | – |
2015 Q1
22 quarters
|
|
|
PBCT
87
DELISTED
People's United Financial Inc
PBCT
| $15K | 0.01% |
1,500
| – | – |
2019 Q1
6 quarters
|
|
88
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $12K | 0.01% |
+5,200
| New | +$14.8K |
2020 Q3
0 quarters
|
|
|
SVC
89
Service Properties Trust
SVC
$796M
| $8K | ﹤0.01% |
200
| – | – |
2015 Q1
22 quarters
|
|
90
Starwood Property Trust
STWD
$4.61B
| $6K | ﹤0.01% |
400
| – | – |
2013 Q2
29 quarters
|
|
91
DELISTED
DigitalBridge
DBRG
| $4K | ﹤0.01% |
367
| – | – |
2017 Q1
14 quarters
|
|
92
Alerian MLP ETF
AMLP
$12.7B
| $2K | ﹤0.01% |
120
| – | – |
2015 Q1
22 quarters
|
|
|
SCU
93
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $2K | ﹤0.01% |
200
| – | – |
2014 Q2
25 quarters
|
|
94
MBody AI Ltd. Ordinary Share
MBAI
$42.1M
| $1K | ﹤0.01% |
16
| – | – |
2018 Q3
8 quarters
|
|
95
Wabtec
WAB
$48.4B
| $1K | ﹤0.01% |
23
| – | – |
2019 Q1
6 quarters
|
|
96
DELISTED
Catalyst Pharmaceutical
CPRX
| – | – |
-42,117
| Closed | -$195K | – |
|
97
Dell
DELL
$287B
| – | – |
-12,678
| Closed | -$353K | – |
|
|
98
Occidental Petroleum Corp Warrants
OXY.WS
$38B
| $0 | ﹤0.01% |
+370
| New | +$1.18K |
2020 Q3
0 quarters
|
|
99
The RMR Group
RMR
$313M
| $0 | ﹤0.01% |
16
| – | – |
2015 Q4
19 quarters
|
|
|
BLU
100
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-238,611
| Closed | -$2.47M | – |
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q3 2020 Portfolio in Review
As of Q3 2020, David M. Knott held 104 positions worth $170M, down 7% from $183M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
David M. Knott withdrew a net $12.5M in Q3 2020, closing 4 positions and reducing 10 holdings. Its most notable exit was BELLUS Health Inc., an estimated $2.47M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 45% a quarter earlier, followed by Financials and Industrials.
Against the trend, David M. Knott opened a new position in Vapotherm, Inc. Common Stock worth $1.42M.
- David M. Knott's largest Q3 2020 buy was Vapotherm, Inc. Common Stock: 6,125 shares worth $1.42M.
- David M. Knott added most to TG Therapeutics in Q3 2020, an estimated $892K increase.
- David M. Knott's biggest Q3 2020 reduction was Stericycle Inc, cutting an estimated $6.7M.
- David M. Knott fully exited BELLUS Health Inc. in Q3 2020, selling an estimated $2.47M.
- David M. Knott's ten largest holdings make up 61% of its $170M portfolio in Q3 2020.
- David M. Knott opened 11 new positions and closed 4 in Q3 2020.
- David M. Knott's portfolio value fell 7% quarter-over-quarter to $170M.
Based on David M. Knott's 13F filing for Q3 2020, filed 13 Nov 2020.